New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 82, Issue 5, Pages 1171-1179Publisher
WILEY
Keywords
Categories
Funding
- Novartis, Germany
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
Morgan Vandermeulen, Pauline Erpicum, Noella Bletard, Laurence Poma, Francois Jouret, Olivier Detry
FRONTIERS IN IMMUNOLOGY (2022)
Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation
Xiaoxiao Xu, Xiaoqin Li, Yanmin Zhao, He Huang
FRONTIERS IN IMMUNOLOGY (2021)
Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation-A Network Meta-Analysis
Sebastian Wolf, Verena S. Hoffmann, Florian Sommer, Matthias Schrempf, Mingming Li, Martin Ryll, Ulrich Wirth, Matthias Ilmer, Jens Werner, Joachim Andrassy
JOURNAL OF CLINICAL MEDICINE (2022)
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis
Karin Garming Legert, Olle Ringden, Mats Remberger, Johan Torlen, Jonas Mattsson, Goran Dahllof
ORAL DISEASES (2021)
Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient's perspective?
Nicolas Leuthold, Marco Cattaneo, Jorg Halter, Claudia Huegli, Monika Kirsch, Anna Petropoulou, Tobias E. Erlanger, Sabine Gerull, Jakob Passweg, Alix O'Meara Stern
SUPPORTIVE CARE IN CANCER (2021)
IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy
Tor Henrik Anderson Tvedt, Stefan Rose-John, Galina Tsykunova, Aymen Bushra Ahmed, Tobias Gedde-Dahl, Elisabeth Ersvaer, Oystein Bruserud
JOURNAL OF CLINICAL MEDICINE (2022)
Graft conditioning with fluticasone propionate reduces graft-versus-host disease upon allogeneic hematopoietic cell transplantation in mice
Erika S. Varady, L. Angel Ayala, Pauline U. Nguyen, Vanessa M. Scarfone, Alborz Karimzadeh, Cuiwen Zhou, Xiyu Chen, Scott A. Greilach, Craig M. Walsh, Matthew A. Inlay
EMBO MOLECULAR MEDICINE (2023)
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma
Fateeha Furqan, Kwang W. Ahn, Yue Chen, Manmeet Kaur, Syed A. Abutalib, Nausheen Ahmed, Sairah Ahmed, Mohamed A. Kharfan-Dabaja, Johnathan Friedberg, Tara Gregory, LaQuisa Hill, Cole Sterling, Stephan K. Barta, Mazyar Shadman, Miguel-Angel Perales, Jasmine Zain, Alex F. Herrera, Craig Sauter, Mehdi Hamadani
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Transitioning tacrolimus to sirolimus in allogeneic hematopoietic cell transplantation
Linda Arrabi, Anna Jan, Chitra Hosing, Denai R. Milton, Jason Yeh
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study.
Elisabetta Bussalino, Luigina Marsano, Angelica Parodi, Rodolfo Russo, Fabio Massarino, Maura Ravera, Gabriele Gaggero, Iris Fontana, Giacomo Garibotto, Gianluigi Zaza, Giovanni Stallone, Ernesto Paoletti
JOURNAL OF NEPHROLOGY (2021)
Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review
Chiara Visintini, Irene Mansutti, Alvisa Palese
CANCERS (2023)
Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
Abu-Sayeef Mirza, Ankita Tandon, Dakota Jenneman, Shu Cao, Thomas Brimer, Ambuj Kumar, Michelle Kidd, Farhad Khimani, Rawan Faramand, Asmita Mishra, Hien Liu, Taiga Nishihori, Lia Perez, Aleksandr Lazaryan, Nelli Bejanyan, Michael Nieder, Claudio Anasetti, Joseph Pidala, Hany Elmariah
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation
Moshe Yeshurun, Oren Pasvolsky, Liat Shargian, Dafna Yahav, Haim Ben-Zvi, Maly Rubinstein, Michal Sela-Navon, Ofir Wolach, Pia Raanani, Uri Rozovski
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation
Cecile Pochon, Anne-Beatrice Notarantonio, Caroline Laroye, Loic Reppel, Daniele Bensoussan, Allan Bertrand, Marie-Therese Rubio, Maud D'Aveni
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation
Amandine Pradier, Samuel Cordey, Marie-Celine Zanella, Astrid Melotti, Sisi Wang, Anne-Claire Mamez, Yves Chalandon, Stavroula Masouridi-Levrat, Laurent Kaiser, Federico Simonetta, Diem-Lan Vu
FRONTIERS IN IMMUNOLOGY (2023)
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
Angelica Cuapio, Caroline Boulouis, Iva Filipovic, David Wullimann, Tobias Kammann, Tiphaine Parrot, Puran Chen, Mira Akber, Yu Gao, Quirin Hammer, Benedikt Strunz, Andre Perez Potti, Olga Rivera Ballesteros, Joshua Lange, Jagadeeswara Rao Muvva, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Soderdahl, Anders Osterborg, C. I. Edvard Smith, Gordana Bogdanovic, Sandra Muschiol, Fredrika Hellgren, Karin Lore, Michal J. Sobkowiak, Giorgio Gabarrini, Katie Healy, Margaret Sallberg Chen, Evren Alici, Niklas K. Bjorkstrom, Marcus Buggert, Per Ljungman, Johan K. Sandberg, Soo Aleman, Hans-Gustaf Ljunggren
MOLECULAR MEDICINE (2022)
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
P. J. Hayden, C. Roddie, P. Bader, G. W. Basak, H. Bonig, C. Bonini, C. Chabannon, F. Ciceri, S. Corbacioglu, R. Ellard, F. Sanchez-Guijo, U. Jaeger, M. Hildebrandt, M. Hudecek, M. J. Kersten, U. Koehl, J. Kuball, S. Mielke, M. Mohty, J. Murray, A. Nagler, J. Rees, C. Rioufol, R. Saccardi, J. A. Snowden, J. Styczynski, M. Subklewe, C. Thieblemont, M. Topp, A. U. Ispizua, D. Chen, R. Vrhovac, J. G. Gribben, N. Kroeger, H. Einsele, I Yakoub-Agha
ANNALS OF ONCOLOGY (2022)
Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
Hannes Lindahl, Sofie Vonlanthen, Davide Valentini, Andreas T. Bjorklund, Mikael Sundin, Stephan Mielke, Dan Hauzenberger
BONE MARROW TRANSPLANTATION (2022)
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
Dawn Swan, Patrick J. Hayden, Dirk-Jan Eikema, Linda Koster, Sandra Sauer, Didier Blaise, Emma Nicholson, Neil Rabin, Cyrille Touzeau, Jennifer Byrne, Anne Huynh, Jan J. Cornelissen, Victoria Potter, Edouard Forcade, Christopher Parrish, John Gribben, Marie-Lorraine Chretien, Stephan Mielke, Tobias Gedde-Dahl, Peter Remenyi, Panagiotis Tsirigotis, Antoni Garcia Guinon, Meral Beksac, Stefan Schonland, Ibrahim Yakoub-Agha
BRITISH JOURNAL OF HAEMATOLOGY (2022)
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
Caroline Boulouis, Tobias Kammann, Angelica Cuapio, Tiphaine Parrot, Yu Gao, Elli Mouchtaridi, David Wullimann, Joshua Lange, Puran Chen, Mira Akber, Olga Rivera Ballesteros, Jagadeeswara Rao Muvva, C. I. Edvard Smith, Jan Vesterbacka, Oscar Kieri, Piotr Nowak, Peter Bergman, Marcus Buggert, Hans-Gustaf Ljunggren, Soo Aleman, Johan K. Sandberg
MOLECULAR MEDICINE (2022)
Unmasking of Metamizole-induced Liver Injury by Simultaneous Development of Characteristic Agranulocytosis
Mathias Lutz, Inga Gruenewald, Frank Lenze, Hauke Heinzow, Hansjorg Ullerich, Iyad Kabar, Hartmut H. Schmidt, Phil-Robin Tepasse
CURRENT DRUG SAFETY (2023)
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT
Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane Apperley, Jenny Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, Francesca Kinsella, Goda Choi, Peter Remenyi, John A. Snowden, Marie Robin, Stig Lenhoff, Stephan Mielke, Jakob Passweg, Annoek E. C. Broers, Nicolaus Kroeger, Zeynep Arzu Yegin, Sen Mui Tan, Patrick J. Hayden, Donal P. McLornan, Ibrahim Yakoub-Agha
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Jeremy S. Abramson, Scott R. Solomon, Jon Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Ken Ogasawara, Manali Kamdar
BLOOD (2023)
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo G. Carrabba, Christian Chabannon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Roch Houot, Gloria Iacoboni, Ulrich Jager, Marie Jose Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermin Sanchez-Guijo, Isabel Sanchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A. Snowden, Catherine Thieblemont, Max Topp, Pier Luigi Zinzani, John G. Gribben, Chiara Bonini, Anna Sureda, Ibrahim Yakoub-Agha
BLOOD (2023)
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Gesine Bug, Myriam Labopin, Riitta Niittyvuopio, Matthias Stelljes, Hans Christian Reinhardt, Inken Hilgendorf, Nicolaus Kroeger, Ain Kaare, Wolfgang Bethge, Kerstin Schaefer-Eckart, Mareike Verbeek, Stephan Mielke, Kristina Carlson, Ali Bazarbachi, Alexandros Spyridonidis, Bipin N. Savani, Arnon Nagler, Mohamad Mohty
BONE MARROW TRANSPLANTATION (2023)
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
Arnon Nagler, Myriam Labopin, Stephan Mielke, Jakob Passweg, Didier Blaise, Tobias Gedde-Dahl, Jan J. J. Cornelissen, Urpu Salmenniemi, Ibrahim Yakoub-Agha, Peter Remenyi, Gerard Socie, Gwendolyn van Gorkom, Helene Labussiere-Wallet, Xiao-Jun Huang, Marie Therese Rubio, Jenny Byrne, Charles Craddock, Laimonas Griskevicius, Fabio Ciceri, Mohamad Mohty
BONE MARROW TRANSPLANTATION (2023)
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
Per Ljungman, Gloria Tridello, Jose Luis Pinana, Fabio Ciceri, Henrik Sengeloev, Alexander Kulagin, Stephan Mielke, Zeynep Arzu Yegin, Matthew Collin, Sigrun Einardottir, Sophie Ducastelle Lepretre, Johan Maertens, Antonio Campos, Elisabetta Metafuni, Herbert Pichler, Frantisek Folber, Carlos Solano, Emma Nicholson, Meltem Kurt Yueksel, Kristina Carlson, Beatriz Aguado, Caroline Besley, Jenny Byrne, Immaculada Heras, Fiona Dignan, Nicolaus Kroeger, Christine Robin, Anjum Khan, Stig Lenhoff, Anna Grassi, Veronika Dobsinska, Nuno Miranda, Maria-Jose Jimenez, Ipek Yonal-Hindilerden, Keith Wilson, Dina Averbuch, Simone Cesaro, Alienor Xhaard, Nina Knelange, Jan Styczynski, Malgorzata Mikulska, Rafael de la Camara
FRONTIERS IN IMMUNOLOGY (2023)
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R. R. Muller, Takuya Sekine, Darya Trubach, Julia Niessl, Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Jan Vesterbacka, Mira Akber, Anna Olofsson, Susana Patricia Amaya Hernandez, Yu Gao, Curtis Cai, Gunnar Soderdahl, C. I. Edvard Smith, Anders Osterborg, Karin Lore, Margaret Sallberg Chen, Per Ljungman, Hans-Gustaf Ljunggren, Annika C. C. Karlsson, Sunil Kumar Saini, Soo Aleman, Marcus Buggert
SCIENCE TRANSLATIONAL MEDICINE (2023)
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, Yuefan Huang, Pinaki P. Banerjee, Qi Miao, Jens G. Lohr, Tushara Vijaykumar, Julia Frede, Birgit Knoechel, Luis Muniz-Feliciano, Tamara J. Laskowski, Shaoheng Liang, Judy S. Moyes, Vandana Nandivada, Rafet Basar, Mecit Kaplan, May Daher, Enli Liu, Ye Li, Sunil Acharya, Paul Lin, Mayra Shanley, Hind Rafei, David Marin, Stephan Mielke, Richard E. Champlin, Elizabeth J. Shpall, Ken Chen, Katayoun Rezvani
SCIENCE ADVANCES (2023)
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID
Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Soderdahl, Anders oesterborg, C. I. Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael aberg, Karin Lore, Margaret Saellberg Chen, Marcus Buggert, Per Ljungman, Soo Aleman, Hans-Gustaf Ljunggren
EBIOMEDICINE (2023)